Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SBPH

Spring Bank Pharmaceuticals

$17.02

0.45 (2.72%)

, GILD

Gilead

$71.81

0.66 (0.93%)

16:35
11/15/17
11/15
16:35
11/15/17
16:35
Hot Stocks
Spring Bank Pharmaceuticals reports 'positive' results from Phase 2 ACHIEVE »

Spring Bank…

SBPH

Spring Bank Pharmaceuticals

$17.02

0.45 (2.72%)

GILD

Gilead

$71.81

0.66 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 12

    Feb

SBPH

Spring Bank Pharmaceuticals

$17.02

0.45 (2.72%)

, GILD

Gilead

$71.81

0.66 (0.93%)

16:34
11/15/17
11/15
16:34
11/15/17
16:34
Hot Stocks
Spring Bank Pharmaceuticals sees positive results from Phase 2 ACHIEVE trial »

Spring Bank…

SBPH

Spring Bank Pharmaceuticals

$17.02

0.45 (2.72%)

GILD

Gilead

$71.81

0.66 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 12

    Feb

Tuesday
GILD

Gilead

$72.85

-0.92 (-1.25%)

11:54
11/14/17
11/14
11:54
11/14/17
11:54
Technical Analysis
Technical View: Gilead falls for second session »

The stock is near the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

Monday
GILD

Gilead

$73.77

0.75 (1.03%)

09:09
11/13/17
11/13
09:09
11/13/17
09:09
Downgrade
Gilead rating change at Argus »

Gilead downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

GILD

Gilead

$73.77

0.75 (1.03%)

08:18
11/13/17
11/13
08:18
11/13/17
08:18
Downgrade
Gilead rating change at Argus »

Gilead downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

AAPL

Apple

$174.67

-1.21 (-0.69%)

, GE

General Electric

$20.49

0.5 (2.50%)

07:35
11/13/17
11/13
07:35
11/13/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

AAPL

Apple

$174.67

-1.21 (-0.69%)

GE

General Electric

$20.49

0.5 (2.50%)

MU

Micron

$44.78

1.28 (2.94%)

NFLX

Netflix

$192.02

-1.88 (-0.97%)

M

Macy's

$19.98

0.48 (2.46%)

GILD

Gilead

$73.77

0.75 (1.03%)

CVS

CVS Health

$70.99

1.97 (2.85%)

CAR

Avis Budget

$33.46

-0.44 (-1.30%)

GRPN

Groupon

$5.37

-0.24 (-4.28%)

ROKU

Roku

$33.25

4.06 (13.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 16

    Nov

  • 12

    Dec

  • 12

    Feb

  • 18

    Mar

Over a week ago
JUNO

Juno Therapeutics

$54.43

-0.53 (-0.96%)

15:45
11/10/17
11/10
15:45
11/10/17
15:45
Options
Juno Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

JNJ

Johnson & Johnson

$139.00

-1.35 (-0.96%)

, GILD

Gilead

$73.02

-0.08 (-0.11%)

12:53
11/10/17
11/10
12:53
11/10/17
12:53
Periodicals
Breaking Periodicals news story on Johnson & Johnson, Gilead, Mylan »

J&J, Gilead settle…

JNJ

Johnson & Johnson

$139.00

-1.35 (-0.96%)

GILD

Gilead

$73.02

-0.08 (-0.11%)

MYL

Mylan

$38.08

0.84 (2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 14

    Dec

  • 12

    Feb

GILD

Gilead

$73.10

-0.11 (-0.15%)

, ANTM

Anthem

$214.86

-2.01 (-0.93%)

13:35
11/09/17
11/09
13:35
11/09/17
13:35
Hot Stocks
Anthem issues updated medical policy for Kite Pharma's Yescarta »

Anthem (ANTM) issued a…

GILD

Gilead

$73.10

-0.11 (-0.15%)

ANTM

Anthem

$214.86

-2.01 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

LLY

Eli Lilly

$83.28

0.34 (0.41%)

, ABBV

AbbVie

$93.96

1 (1.08%)

04:55
11/08/17
11/08
04:55
11/08/17
04:55
Conference/Events
American College of Rheumatology City to hold annual meeting »

Annual Meeting of…

LLY

Eli Lilly

$83.28

0.34 (0.41%)

ABBV

AbbVie

$93.96

1 (1.08%)

AMGN

Amgen

$173.48

2.68 (1.57%)

BIIB

Biogen

$313.57

-1.9 (-0.60%)

CELG

Celgene

$102.33

0.69 (0.68%)

FLXN

Flexion

$23.71

0.24 (1.02%)

DGX

Quest Diagnostics

$92.66

-0.49 (-0.53%)

RHHBY

Roche

$28.95

-0.27 (-0.92%)

GILD

Gilead

$73.21

0.83 (1.15%)

GSK

GlaxoSmithKline

$35.82

-0.32 (-0.89%)

HZNP

Horizon Pharma

$14.00

-0.35 (-2.44%)

IRWD

Ironwood

$15.13

-0.1 (-0.66%)

MNK

Mallinckrodt

$20.11

-11.07 (-35.50%)

MCK

McKesson

$136.93

1.72 (1.27%)

NAVB

Navidea

$0.43

-0.0016 (-0.37%)

NVS

Novartis

$82.39

-1.11 (-1.33%)

OPHM

OraPharma

PFE

Pfizer

$35.36

0.04 (0.11%)

QDEL

Quidel

$37.66

-1.04 (-2.69%)

REGN

Regeneron

$404.39

-2.24 (-0.55%)

SNY

Sanofi

$45.58

-0.49 (-1.06%)

ZYNE

Zynerba

$10.83

-0.36 (-3.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 09

    Nov

  • 11

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 28

    Nov

  • 29

    Nov

  • 30

    Nov

  • 30

    Nov

  • 30

    Nov

  • 02

    Dec

  • 04

    Dec

  • 09

    Dec

  • 14

    Dec

  • 23

    Dec

  • 03

    Feb

  • 12

    Feb

  • 23

    Feb

  • 30

    Apr

  • 17

    May

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.